Claude AI discovers CRISPR-like enzyme system in phage DNA

Overview

Updated 1 hour ago

Anthropic's Claude AI spent 21 hours autonomously searching a database of 200,000+ reverse transcriptase enzymes. It flagged an unusual enzyme paired with a repeating DNA pattern, a layout reminiscent of CRISPR.

The company's lab confirmed the pattern, named array-associated reverse transcriptases (ART), in bacteriophages — the viruses that infect bacteria. Its function is unknown, but the architecture resembles known programmable systems that cut, copy, and paste DNA.

CRISPR researchers say this is routine genome mining, with similar systems known since 2008. Nothing yet shows ART can edit genes — but the autonomy of the search is what's new.

Why it matters

If ART proves programmable, it could become a new gene-editing tool. The larger shift: AI agents now drive biological discovery from search to lab test.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

200,000+

Reverse transcriptases examined by Claude agents

Claude agents gathered more than 200,000 RTs from a DNA database before narrowing focus.

3,500

Candidate systems identified

Claude selected 3,500 new candidates and picked 20 for detailed analysis.

Share of phage RNA from ART transcripts

In a Staphylococcus phage, ART array-derived RNA reached 8% of phage RNA 15 minutes after infection.

21 hours

Duration of autonomous database search

Roughly 950 Claude agents used 210 million tokens to complete the search.

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

People Involved

Claude (Anthropic AI model)

Autonomous discovery agent that identified ART

Identified ART after a 21-hour autonomous database search

Dario Amodei

Chief executive of Anthropic

Leading the company behind the ART discovery

Lucas Harrington

Co-founder of Mammoth Biosciences

Skeptical of the announcement's novelty

Kevin Blake

Microbiologist at Washington University School of Medicine

Skeptical of ART's significance as a gene-editing tool

Organizations Involved

Anthropic

AI company

Discovered and announced the ART enzyme system

San Francisco-based AI company that builds the Claude model and led the research program that found ART.

Mammoth Biosciences

Biotechnology company

Offered skeptical commentary on the discovery

Uses genome mining to discover CRISPR systems, the same general approach Anthropic employed.

Timeline

2 events Latest: 2 days ago

September 2026
Anthropic publishes preprint announcing ART enzyme system
Latest Publication

Claude agents searched for 21 hours, examined 200,000+ reverse transcriptases, and flagged the ART pattern. Lab tests confirmed the array produces distinct short RNAs.
2 days ago
CRISPR researchers call finding routine genome mining
Reaction

Lucas Harrington notes similar systems known since 2008; Kevin Blake says nothing indicates ART is a rival to CRISPR-the-technology.
2 days ago

Scenarios

ART confirmed as a functional programmable system

Unlikely Resolves by Q3 2027

Discussed by: Anthropic's research team, whose preprint describes ART's architecture as resembling programmable systems

Lab experiments show the ART reverse transcriptase is enzymatically active, processes array-derived RNA, and performs a programmable operation analogous to CRISPR's spacer bank. That result could make ART a new molecular tool. It would also validate Anthropic's autonomous approach as a genuine discovery engine rather than confirmation of known biology.

ART's natural function found, but it's no gene editor

Possible Resolves by Q3 2027

Discussed by: Microbiologists like Kevin Blake, who note ART resembles RT-associated defense systems already catalogued

Researchers determine ART's native role — likely a defense system in the phage-bacteria arms race — and show whether the RT is active. That yields insight into RT biology but no programmable editing capability. ART becomes a data point on a long list of genome-mined systems that never became tools.

ART research stalls, function never confirmed

Possible Resolves by Q3 2027

Discussed by: Lucas Harrington of Mammoth Biosciences, who calls the finding routine genome mining

No lab produces evidence the ART reverse transcriptase is active or that its RNA array is processed. The system fades from attention, joining the many CRISPR-like sequences in unstudied bacteria that Blake says remain uncatalogued. The episode matters mainly as a demonstration of AI autonomy, not as a biological breakthrough.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1987

CRISPR repeats first observed (1987)

Yoshizumi Ishino's lab at Osaka University reported odd repeated DNA sequences in E. coli with no known function. The pattern, later named CRISPR, sat unexplained for years.

Then

The repeats were cataloged as biological curiosities; researchers had no idea they encoded an adaptive immune system.

Now

In 2012, Jennifer Doudna and Emmanuelle Charpentier showed CRISPR-Cas9 could be programmed to edit DNA, a discovery that won the 2020 Nobel Prize in Chemistry.

Why this matters now

ART is a similarly odd repeating pattern with unknown function. The open question is whether it follows CRISPR's path to utility or stays a curiosity.

2008–2026

Genome mining for CRISPR and RT systems (2008–present)

Labs have spent nearly two decades scanning microbial DNA databases for CRISPR-Cas and reverse-transcriptase systems. Companies like Mammoth Biosciences built their businesses on this approach, which has produced many candidate systems.

Then

Most mined systems never become tools; the field treats them as raw material.

Now

The approach became standard practice, which is why Lucas Harrington calls Anthropic's search routine.

Why this matters now

Anthropic's contribution is autonomy: AI agents decided which leads to pursue and flagged ART for lab tests. The mining method itself is not new.